- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Gendex piques Picker's interest
Multimodality vendor Picker Internationalmay be a potential suitor for x-ray and mammography vendor Gendex,which was put on the block last month by owner Dentsply International(SCAN 10/26/94). Picker is "interested" in Gendex, accordingto
Multimodality vendor Picker Internationalmay be a potential suitor for x-ray and mammography vendor Gendex,which was put on the block last month by owner Dentsply International(SCAN 10/26/94). Picker is "interested" in Gendex, accordingto spokesperson Mike Peterson. He declined to elaborate further.
Dentsply announced in October that it plans to divest its medicaloperations and focus on its core dental business. Dentsply signedan agreement to sell x-ray tube manufacturer Eureka X-Ray Tubeto Varian Associates.
In other Picker news, the Cleveland vendor announced that ithas acquired the manufacturing and distribution rights to KubotaGraphics' Denali 3-D graphics processor. The processor is integratedwith Digital Equipment's Alpha hardware in Picker's Odyssey VPnuclear medicine workstation. The acquisition should improve Picker'sposition in complex 3-D display, particularly in nuclear cardiologyapplications, according to the company.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
Could a Deep Learning Model for Mammography Improve Prediction of DCIS and Invasive Breast Cancer?
April 15th 2024Artificial intelligence (AI) assessment of mammography images may significantly enhance the prediction of invasive breast cancer and ductal carcinoma in situ (DCIS) in women with breast cancer, according to new research presented at the Society for Breast Imaging (SBI) conference.
